Zobrazeno 1 - 10
of 233
pro vyhledávání: '"Hovinga C"'
Autor:
Wilk J; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.; Department of Mathematics, College of Sciences, University of Central Florida, Orlando, Florida, USA., Aggarwal V; Critical Path Institute (C-Path), Tucson, Arizona, USA., Pauley M; Critical Path Institute (C-Path), Tucson, Arizona, USA., Corey D; Critical Path Institute (C-Path), Tucson, Arizona, USA., Conrado DJ; e-Quantify LLC, La Jolla, California, USA., Lingineni K; Novartis Pharmaceutical Corporation, Cambridge, Massachusetts, USA., Morales JF; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.; Critical Path Institute (C-Path), Tucson, Arizona, USA., Yoon DY; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA., Zhang Y; Critical Path Institute (C-Path), Tucson, Arizona, USA., Cui Z; Critical Path Institute (C-Path), Tucson, Arizona, USA., Burton J; Biogen, Cambridge, Massachusetts, USA., Larkindale J; Critical Path Institute (C-Path), Tucson, Arizona, USA., Ma SC; Critical Path Institute (C-Path), Tucson, Arizona, USA., Hovinga C; Critical Path Institute (C-Path), Tucson, Arizona, USA., Martinez T; Critical Path Institute (C-Path), Tucson, Arizona, USA., Romero K; Critical Path Institute (C-Path), Tucson, Arizona, USA., Belfiore-Oshan R; Critical Path Institute (C-Path), Tucson, Arizona, USA., Kim S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.
Autor:
Bierer BE; Division of Global Health Equity, Department of Medicine, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, United States., Koppelman E; Division of Global Health Equity, Department of Medicine, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Brigham and Women's Hospital, Boston, MA, United States., Croker AK; Health Canada, Centre for Policy, Pediatrics and International Collaboration at Health Canada, Ottawa, ON, Canada., Hosseinzadeh S; Global Head Clinical Patient Engagement, Chief Medical Office, Novartis Pharma, Toronto, ON, Canada., Hovinga C; Critical Path Institute (C-Path), Tuscon, AZ, United States., Joffe S; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., McMillan G; Independent Patient & Participant Advocate, Los Angeles, CA, United States., Nelson R; Johnson & Johnson, Pediatric Drug Development, Spring House, PA, United States., Bucci-Rechtweg C; Maternal Health and Pediatric Regulatory Policy, Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.
Publikováno v:
Frontiers in pediatrics [Front Pediatr] 2024 Nov 12; Vol. 12, pp. 1481754. Date of Electronic Publication: 2024 Nov 12 (Print Publication: 2024).
Autor:
Degraeuwe E; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Hovinga C; Critical Path Institute, Tucson, AZ, United States., De Maré A; The Department of Pediatrics, University Hospital of Ghent, ERKNET Centre, Ghent, Belgium., Fernandes RM; conect4children Stichting, Utrecht, Netherlands.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Heaton C; Institute for Advanced Clinical Trials for Children, Rockville, MD, United States., Nuytinck L; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Persijn L; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; The Department of Pediatrics, University Hospital of Ghent, ERKNET Centre, Ghent, Belgium., Raes A; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; The Department of Pediatrics, University Hospital of Ghent, ERKNET Centre, Ghent, Belgium., Vande Walle J; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; The Department of Pediatrics, University Hospital of Ghent, ERKNET Centre, Ghent, Belgium., Turner MA; conect4children Stichting, Utrecht, Netherlands.; Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
Publikováno v:
Frontiers in pediatrics [Front Pediatr] 2024 Nov 07; Vol. 12, pp. 1388170. Date of Electronic Publication: 2024 Nov 07 (Print Publication: 2024).
Autor:
Attar S; Department of Women's and Children's Health, Liverpool Women's NHS Foundation Trust, University of Liverpool, Crown Street, Liverpool, L8 7SS, UK. sgattar@liverpool.ac.uk.; conect4children Stichting, Utrecht, The Netherlands. sgattar@liverpool.ac.uk., Price A; Site Network - Quality Improvement, Institute for Advanced Clinical Trials for Children, 9200 Corporate Blvd, Suite 350, Rockville, MD, 20850, USA., Hovinga C; Clinical and Scientific Development, Institute for Advanced Clinical Trials for Children, 9200 Corporate Blvd, Suite 350, Rockville, MD, 20850, USA., Stewart B; Clinical Trials Office, College of Health Sciences, Faculty of Medicine and Dentistry, University of Alberta, 400 College Plaza 8215 - 112 Street, Edmonton, AB, T6G 2C8, Canada.; Maternal Infant Child Youth Research Network, Vancouver, BC, Canada., Lacaze-Masmonteil T; Maternal Infant Child Youth Research Network, Vancouver, BC, Canada.; Department of Pediatrics, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr NW, Calgary, AB, T2N 4N1, Canada., Bonifazi F; Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Via Abate Eustasio, 30, 70010, Valenzano, BA, Italy., Turner MA; conect4children Stichting, Utrecht, The Netherlands.; Institute of Life Course and Medical Sciences, Liverpool Women's NHS Foundation Trust, University of Liverpool, Crown Street, Liverpool, L8 7SS, UK.; Liverpool Health Partners, Liverpool, UK., Fernandes RM; conect4children Stichting, Utrecht, The Netherlands.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Av. Prof. Egas Moniz MB, 1649-028, Lisbon, Portugal.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Sep; Vol. 58 (5), pp. 953-964. Date of Electronic Publication: 2024 Jun 20.
Autor:
Belfiore-Oshan, R., Aggarwal, V., Wilk, J., Pauley, M., Corey, D., Romero, K., Hovinga, C., Martinez, T., Lingineni, K., Yoon, D., Morales, J., Kim, S.
Publikováno v:
In Neuromuscular Disorders October 2023 33 Supplement 1:S84-S84
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Greenberg RG; Duke Clinical Research Institute, Durham, NC, USA. rachel.greenberg@duke.edu.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA. rachel.greenberg@duke.edu., McCune S; Rare Diseases and Pediatrics Center of Excellence, PPD, Part of Thermo Fisher Scientific, Bethesda, MD, USA., Attar S; Department of Women's and Children's Health, University of Liverpool, Liverpool, UK., Hovinga C; Institute for Advanced Clinical Trials for Children, Rockville, MD, USA., Stewart B; Quality Management in Clinical Research (QMCR), University of Alberta, Edmonton, AB, Canada., Lacaze-Masmonteil T; Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2022 Nov; Vol. 56 (6), pp. 934-947. Date of Electronic Publication: 2022 Sep 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Noel GJ; The Institute for Advanced Clinical Trials for Children, 9211 Corporate Blvd. Suite 260, Rockville, MD, 20850, USA. Gary.noel@iactc.org.; Weill-Cornell Medical College, New York, NY, USA. Gary.noel@iactc.org., Nelson RM; Johnson & Johnson, Spring House, PA, USA., Bucci-Rechtweg C; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Portman R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Miller T; Bayer US, Whippany, NJ, USA., Green DJ; US Food and Drug Administration, Silver Spring, MD, USA., Snyder D; US Food and Drug Administration, Silver Spring, MD, USA., Moreno C; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain., Hovinga C; The Institute for Advanced Clinical Trials for Children, 9211 Corporate Blvd. Suite 260, Rockville, MD, 20850, USA., Connor E; The Institute for Advanced Clinical Trials for Children, 9211 Corporate Blvd. Suite 260, Rockville, MD, 20850, USA.; George Washington School of Medicine, Washington, DC, USA.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2021 Jul; Vol. 55 (4), pp. 773-778. Date of Electronic Publication: 2021 Apr 02.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.